Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies
Doruk Erkan, Silvia S. Pierangeli
Springer Science & Business Media, May 19, 2012 - Medical - 314 pages
The International Congress on Antiphospholipid Antibodies is held every three years to discuss the recent advances and future directions in Antiphospholipid Syndrome (APS). This volume collects the scientific highlights and new findings about APS that were generated from the most recent 13th Congress, held in Galveston, Texas in 2010. Chapters were written by an internationally-distinguished group of scientists from the point-of-view of multiple specialty areas. Each chapter was written in a uniform and systematic basis to present the latest evidence-based research, including the basic science of APS, task force reports from the Congress on controversial aspects of APS, and future directions of APS research. This book will appeal to all clinicians involved in the treatment and management of APS patients, to residents in a variety of medical subspecialties, and to research scientists interested in a better understanding of this complex and evolving disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Antiphospholipid Syndrome: Insights and Highlights from the 13th ...
Doruk Erkan,Silvia S. Pierangeli
No preview available - 2014
13th International Congress and/or Ann Rheum annexin A5 anticardiolipin antibodies antigen antiphospholipid syndrome APS aPL tests aPL-mediated aPL-positive patients APS nephropathy APS patients arterial Arthritis Rheum aspirin assays associated Atsumi autoantibodies autoimmune diseases b2GPI beta2-glycoprotein binding catastrophic antiphospholipid syndrome Cervera Clin clinical manifestations coagulation Congress on Antiphospholipid diagnosis endothelial cells Erkan fetal loss gene glycoprotein heparin Hydroxychloroquine immune Immunol induced inhibitor inhibits Khamashta laboratory lesions livedo reticularis lupus anticoagulant mechanisms Medical mice monoclonal monocytes obstetric pathogenic pathway patients with antiphospholipid patients with APS peptide phospholipids Pierangeli SS placental plasma platelet polymorphism positive aPL pregnancy loss pregnancy morbidity primary antiphospholipid syndrome primary APS protein prothrombin receptor recurrent renal reported Research Rheumatol Rheumatology risk factors rivaroxaban role Springer Science+Business Media stroke systemic lupus erythematosus target task force therapy Thromb Haemost thrombin thrombocytopenia thrombotic tissue factor treatment trophoblast valvular vascular venous vitro vivo